2 results
Approved WMORecruiting
To find a simple test to explain non-responsiveness to sumatriptan in a proportion of patients with migraine.
Approved WMOCompleted
This study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of MTAU9937A in patients with prodromal or mild Alzheimer*s disease (AD), ages 50*80, who are amyloid positive by cerebrospinal fluid (CSF) or amyloid positron…